Isolation of cell-free bacterial inclusion bodies

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Rodríguez Carmona, Escarlata ^a,b   Cano Garrido, Olivia ^a,b   Seras Franzoso, Joaquin ^a,b   Villaverde, Antonio ^a,b   García Fruitós, Elena ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; LYSOZYME; RECOMBINANT PROTEIN; SURFACTANT;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM ISOLATION; CELL COUNT; CELL DISRUPTION; CELL FREE SYSTEM; CELL NUCLEUS INCLUSION BODY; CELL VIABILITY; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; PLASMID; PROCESS DEVELOPMENT; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN VARIANT; SCANNING ELECTRON MICROSCOPY; CELL INCLUSION; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PRESSURE; ULTRASOUND;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA;

ESCHERICHIA COLI; INCLUSION BODIES; MURAMIDASE; PRESSURE; RECOMBINANT PROTEINS; SONICATION; SURFACE-ACTIVE AGENTS;

EID: 77957373529     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-71     Document Type: Article

References (62)

1. Marston FA. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem J 1986, 240:1-12. 1147368, 3548705.
2. Garcia-Fruitos E, Rodriguez-Carmona E, Diez-Gil C, Ferraz RM, Vazquez E, Corchero JL, et al. Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial. Adv Mater 2009, 21:4249.
3. Ventura S, Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol 2006, 24:179-185. 10.1016/j.tibtech.2006.02.007, 16503059.
4. Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Recombinant protein solubility-does more mean better?. Nat Biotechnol 2007, 25:718-720. 10.1038/nbt0707-718, 17621288.
5. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact 2008, 7:34. 10.1186/1475-2859-7-34, 2630956, 19046444.
6. Martinez-Alonso M, Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact 2009, 8:4. 10.1186/1475-2859-8-4, 2630952, 19133126.
7. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A, et al. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 2005, 4:27. 10.1186/1475-2859-4-27, 1224866, 16156893.
8. Carrio MM, Corchero JL, Villaverde A. Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria. FEMS Microbiol Lett 1998, 169:9-15. 10.1016/S0378-1097(98)00444-3, 9851031.
9. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S. Amyloid-like properties of bacterial inclusion bodies. J Mol Biol 2005, 347:1025-1037. 10.1016/j.jmb.2005.02.030, 15784261.
10. Speed MA, Wang DI, King J. Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat Biotechnol 1996, 14:1283-1287. 10.1038/nbt1096-1283, 9631094.
11. Garcia-Fruitos E, Villaverde A. Friendly production of bacterial inclusion bodies. Korean J Chem Eng 2010, 27:385-389.
12. Dalby MJ. Nanostructured surfaces: cell engineering and cell biology. Nanomedicine-UK 2009, 4:247-248.
13. Diez-Gil C, Krabbenborg S, Garcia-Fruitos E, Vazquez E, Rodriguez-Carmona E, Ratera I, et al. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials 2010, 31:5805-5812. 10.1016/j.biomaterials.2010.04.008, 20452667.
14. Garcia-Fruitos E, Seras-Franzoso J, Vazquez E, Villaverde A. Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology 2010, 21:205101. 10.1088/0957-4484/21/20/205101, 20413834.
15. Vallejo LF, Rinas U. Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact 2004, 3:11. 10.1186/1475-2859-3-11, 517725, 15345063.
16. Rudolph R, Lilie H. In vitro folding of inclusion body proteins. FASEB J 1996, 10:49-56.
17. Vallejo LF, Brokelmann M, Marten S, Trappe S, Cabrera-Crespo J, Hoffmann A, et al. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 2002, 94:185-194. 10.1016/S0168-1656(01)00425-4, 11796171.
18. Clark ED. Protein refolding for industrial processes. Curr Opin Biotechnol 2001, 12:202-207. 10.1016/S0958-1669(00)00200-7, 11287238.
19. Carrio MM, Corchero JL, Villaverde A. Proteolytic digestion of bacterial inclusion body proteins during dynamic transition between soluble and insoluble forms. Biochim Biophys Acta 1999, 1434:170-176.
20. Carrio MM, Cubarsi R, Villaverde A. Fine architecture of bacterial inclusion bodies. FEBS Lett 2000, 471:7-11. 10.1016/S0014-5793(00)01357-0, 10760503.
21. Cubarsi R, Carrio MM, Villaverde A. In situ proteolytic digestion of inclusion body polypeptides occurs as a cascade process. Biochem Biophys Res Commun 2001, 282:436-441. 10.1006/bbrc.2001.4583, 11401478.
22. Corchero JL, Viaplana E, Benito A, Villaverde A. The position of the heterologous domain can influence the solubility and proteolysis of beta-galactosidase fusion proteins in E. coli. J Biotechnol 1996, 48:191-200. 10.1016/0168-1656(96)01508-8, 8861998.
23. Carrio MM, Villaverde A. Protein aggregation as bacterial inclusion bodies is reversible. FEBS Lett 2001, 489:29-33. 10.1016/S0014-5793(01)02073-7, 11231008.
24. Carrio MM, Villaverde A. Role of molecular chaperones in inclusion body formation. FEBS Lett 2003, 537:215-221. 10.1016/S0014-5793(03)00126-1, 12606060.
25. Petersson L, Carrio MM, Vera A, Villaverde A. The impact of dnaKJ overexpression on recombinant protein solubility results from antagonistic effects on the control of protein quality. Biotechnol Lett 2004, 26:595-601. 10.1023/B:BILE.0000021963.31863.a4, 15168861.
26. Gonzalez-Montalban N, Garcia-Fruitos E, Ventura S, Aris A, Villaverde A. The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells. Microb Cell Fact 2006, 5:26. 10.1186/1475-2859-5-26, 1555604, 16893469.
27. Gonzalez-Montalban N, Natalello A, Garcia-Fruitos E, Villaverde A, Doglia SM. In situ protein folding and activation in bacterial inclusion bodies. Biotechnol Bioeng 2008, 100:797-802. 10.1002/bit.21797, 18351678.
28. Garcia-Fruitos E, Martinez-Alonso M, Gonzalez-Montalban N, Valli M, Mattanovich D, Villaverde A. Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J Mol Biol 2007, 374:195-205. 10.1016/j.jmb.2007.09.004, 17920630.
29. Martinez-Alonso M, Garcia-Fruitos E, Villaverde A. Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli. Biotechnol Bioeng 2008, 101:1353-1358. 10.1002/bit.21996, 18980180.
30. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, Fernandez-Busquets X, et al. Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim Biophys Acta 2008, 1783:1815-1825. 10.1016/j.bbamcr.2008.06.007, 18619498.
31. Bowden GA, Paredes AM, Georgiou G. Structure and morphology of protein inclusion bodies in Escherichia coli. Nat Biotechnol 1991, 9:725-730.
32. Taylor G, Hoare M, Gray DR, Marston FAO. Size and Density of Protein Inclusion-Bodies. Nat Biotechnol 1986, 4:553-557.
33. Sabate R, Espargaro A, Saupe SJ, Ventura S. Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion. Microb Cell Fact 2009, 8:56. 10.1186/1475-2859-8-56, 2774669, 19863787.
34. Espargaro A, Sabate R, Ventura S. Kinetic and thermodynamic stability of bacterial intracellular aggregates. FEBS Lett 2008, 582:3669-3673. 10.1016/j.febslet.2008.09.049, 18840434.
35. Arie JP, Miot M, Sassoon N, Betton JM. Formation of active inclusion bodies in the periplasm of Escherichia coli. Mol Microbiol 2006, 62:427-437. 10.1111/j.1365-2958.2006.05394.x, 17020581.
36. Nahalka J, Vikartovska A, Hrabarova E. A crosslinked inclusion body process for sialic acid synthesis. J Biotechnol 2008, 134:146-153. 10.1016/j.jbiotec.2008.01.014, 18313163.
37. Nahalka J. Physiological aggregation of maltodextrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to alpha-D-glucose-1-phosphate. J Ind Microbiol Biotechnol 2008, 35:219-223. 10.1007/s10295-007-0287-4, 18087736.
38. Nahalka J, Mislovicova D, Kavcova H. Targeting lectin activity into inclusion bodies for the characterisation of glycoproteins. Mol Biosyst 2009, 5:819-821. 10.1039/b900526a, 19603115.
39. Vallejo LF, Rinas U. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration. Biotechnol Bioeng 2004, 85:601-609. 10.1002/bit.10906, 14966801.
40. Peternel S, Jevsevar S, Bele M, Gaberc-Porekar V, Menart V. New properties of inclusion bodies with implications for biotechnology. Biotechnol Appl Biochem 2008, 49:239-246. 10.1042/BA20070140, 17708747.
41. Tran-Moseman A, Schauer N, De Bernardez CE. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor. Protein Expr Purif 1999, 16:181-189. 10.1006/prep.1999.1074, 10336876.
42. Batas B, Schiraldi C, Chaudhuri JB. Inclusion body purification and protein refolding using microfiltration and size exclusion chromatography. J Biotechnol 1999, 68:149-158. 10.1016/S0168-1656(98)00197-7, 10194854.
43. Novak S, Maver U, Peternel S, Venturini P, Bele M, Gaberscek M. Electrophoretic deposition as a tool for separation of protein inclusion bodies from host bacteria in suspension. Colloid Surface A 2009, 340:155-160.
44. Tokatlidis K, Dhurjati P, Millet J, Beguin P, Aubert JP. High activity of inclusion bodies formed in Escherichia coli overproducing Clostridium thermocellum endoglucanase D. FEBS Lett 1991, 282:205-208. 10.1016/0014-5793(91)80478-L, 2026260.
45. Nahalka J, Nidetzky B. Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilis D-amino acid oxidase as insoluble enzyme aggregates. Biotechnol Bioeng 2007, 97:454-461. 10.1002/bit.21244, 17089401.
46. Nahalka J, Dib I, Nidetzky B. Encapsulation of Trigonopsis variabilis D-amino acid oxidase and fast comparison of the operational stabilities of free and immobilized preparations of the enzyme. Biotechnol Bioeng 2008, 99:251-260. 10.1002/bit.21579, 17680679.
47. Li M, Poliakov A, Danielson UH, Su Z, Janson JC. Refolding of a recombinant full-length non-structural (NS3) protein from hepatitis C virus by chromatographic procedures. Biotechnol Lett 2003, 25:1729-1734. 10.1023/A:1026050627117, 14626416.
48. Babu KR, Swaminathan S, Marten S, Khanna N, Rinas U. Production of interferon-alpha in high cell density cultures of recombinant Escherichia coli and its single step purification from refolded inclusion body proteins. Appl Microbiol Biotechnol 2000, 53:655-660. 10.1007/s002530000318, 10919322.
49. Worrall DM, Goss NH. The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli. Aust J Biotechnol 1989, 3:28-32.
50. Baranauskaite L, Sereikaite J, Gedminiene G, Bumeliene Z, Bumelis VA. Refolding of porcine growth hormone from inclusion bodies of Escherichia coli. Biocatal Biotransfor 2005, 23:185-189.
51. Rinas U, Bailey JE. Overexpression of bacterial hemoglobin causes incorporation of pre-beta-lactamase into cytoplasmic inclusion bodies. Appl Environ Microbiol 1993, 59:561-566. 202144, 8382023.
52. Kuhelj R, Dolinar M, Pungercar J, Turk V. The preparation of catalytically active human cathepsin B from its precursor expressed in Escherichia coli in the form of inclusion bodies. Eur J Biochem 1995, 229:533-539. 10.1111/j.1432-1033.1995.0533k.x, 7744077.
53. Kaar W, Ahrer K, Durauer A, Greinstetter S, Sprinzl W, Wechner P, et al. Refolding of Npro fusion proteins. Biotechnol Bioeng 2009, 104:774-784.
54. Menzella HG, Gramajo HC, Ceccarelli EA. High recovery of prochymosin from inclusion bodies using controlled air oxidation. Protein Expr Purif 2002, 25:248-255. 10.1016/S1046-5928(02)00006-2, 12135557.
55. Kuczynska-Wisnik D, Zurawa-Janicka D, Narkiewicz J, Kwiatkowska J, Lipinska B, Laskowska E. Escherichia coli small heat shock proteins IbpA/B enhance activity of enzymes sequestered in inclusion bodies. Acta Biochim Pol 2004, 51:925-931.
56. Schrodel A, de MA. Characterization of the aggregates formed during recombinant protein expression in bacteria. BMC Biochem 2005, 6:10. 10.1186/1471-2091-6-10, 1175841, 15927061.
57. Schrodel A, Volz J, de Marco A. Fusion tags and chaperone co-expression modulate both the solubility and the inclusion body features of the recombinant CLIPB14 serine protease. J Biotechnol 2005, 120:2-10. 10.1016/j.jbiotec.2005.04.028, 16023240.
58. Rehm BH, Qi Q, Beermann BB, Hinz HJ, Steinbuchel A. Matrix-assisted in vitro refolding of Pseudomonas aeruginosa class II polyhydroxyalkanoate synthase from inclusion bodies produced in recombinant Escherichia coli. Biochem J 2001, 358:263-268. 10.1042/0264-6021:3580263, 1222056, 11485576.
59. Villa R, Lotti M, Gatti-Lafranconi P. Components of the E. coli envelope are affected by and can react to protein over-production in the cytoplasm. Microb Cell Fact 2009, 8:32. 10.1186/1475-2859-8-32, 2701923, 19500339.
60. Ami D, Natalello A, Schultz T, Gatti-Lafranconi P, Lotti M, Doglia SM, et al. Effects of recombinant protein misfolding and aggregation on bacterial membranes. Biochim Biophys Acta 2009, 1794:263-269.
61. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning, A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
62. Thomas JG, Baneyx F. Roles of the Escherichia coli small heat shock proteins IbpA and IbpB in thermal stress management: comparison with ClpA, ClpB, and HtpG In vivo. J Bacteriol 1998, 180:5165-5172. 107554, 9748451.